MYLS22
CAS No. 306959-01-3
MYLS22 ( —— )
产品货号. M23118 CAS No. 306959-01-3
MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥284 | 有现货 |
|
5MG | ¥462 | 有现货 |
|
10MG | ¥786 | 有现货 |
|
25MG | ¥1345 | 有现货 |
|
50MG | ¥2049 | 有现货 |
|
100MG | ¥3167 | 有现货 |
|
200MG | ¥4755 | 有现货 |
|
500MG | ¥7525 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称MYLS22
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor.
-
产品描述MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor. MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体OPA1
-
研究领域——
-
适应症——
化学信息
-
CAS Number306959-01-3
-
分子量443.5
-
分子式C??H??N?O?S
-
纯度>98% (HPLC)
-
溶解度DMSO : 50 mg/mL (112.73 mM; ultrasonic and warming and heat to 60°C)
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Stéphanie Herkenne, et al. Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1. Cell Metab. 2020 May 5;31(5):987-1003.e8.
产品手册
关联产品
-
(R,S)-Equol
S-equol and R/S-equol estrogen receptor α2-selective phytoSERM treatments have potentiation of brain mitochondrial function.
-
Microhelenin C
Microhelenin C has significant antileukemic activity.
-
Fuzitine
The flowers of Magnolia liliiflora Desr.